| Bacillus spizizenii |
Bacillus spizizenii |
IZ |
8.5 |
mm |
10.1021/jm00205a004 |
| Bacillus spizizenii |
Bacillus spizizenii |
IZ |
11.1 |
mm |
10.1021/jm00205a004 |
| Bacillus spizizenii |
Bacillus spizizenii |
IZ |
14.3 |
mm |
10.1021/jm00205a004 |
| Bacillus spizizenii |
Bacillus spizizenii |
IZ |
14.5 |
mm |
10.1021/jm00205a004 |
| Bacillus spizizenii |
Bacillus spizizenii |
IZ |
16.6 |
mm |
10.1021/jm00205a004 |
| Bacillus spizizenii |
Bacillus spizizenii |
IZ |
18.2 |
mm |
10.1021/jm00205a004 |
| Bacillus spizizenii |
Bacillus spizizenii |
MIC |
0.002 |
ug.mL-1 |
10.1021/acs.jnatprod.6b00742 |
| Bacillus subtilis |
Bacillus subtilis |
ID50 |
0.05 |
ug ml-1 |
10.1021/jm00228a006 |
| Bacillus subtilis |
Bacillus subtilis |
IZ |
55.0 |
mm |
10.1021/np060063g |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
0.09 |
ug.mL-1 |
10.1021/jm00108a009 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
0.09 |
ug.mL-1 |
10.1021/jm00228a006 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
0.78 |
ug.mL-1 |
10.1021/np990416u |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
100.0 |
ug.mL-1 |
10.1021/np0602057 |
| Bacillus thuringiensis |
Bacillus thuringiensis |
MIC |
0.06 |
ug.mL-1 |
10.1021/acs.jnatprod.1c00294 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
IC50 |
0.2 |
ug.mL-1 |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
7.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
16.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
17.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
30.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
44.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
54.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
61.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
62.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
72.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
79.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
89.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
92.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
93.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
95.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
96.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
99.0 |
% |
10.1021/jm00195a008 |
| Bacteria |
Bacterial DNA-directed RNA polymerase |
Inhibition |
100.0 |
% |
10.1021/jm00195a008 |
| Bos taurus |
Bos taurus |
Delta Tm |
7.1 |
None |
10.1021/jm00141a007 |
| Bos taurus |
Bos taurus |
Tm |
7.1 |
None |
10.1021/jm00403a010 |
| Bos taurus |
Calf thymus DNA |
Activity |
30.0 |
% |
10.1021/jm00205a004 |
| Bos taurus |
Calf thymus DNA |
Activity |
30.0 |
% |
10.1021/np50078a006 |
| Bos taurus |
Calf thymus DNA |
Activity |
70.0 |
% |
10.1021/jm00205a004 |
| Bos taurus |
Calf thymus DNA |
Activity |
85.0 |
% |
10.1021/jm00205a004 |
| Bos taurus |
Calf thymus DNA |
Activity |
nan |
None |
10.1021/jm00195a008 |
| Bos taurus |
Calf thymus DNA |
Activity |
nan |
None |
10.1021/jm00205a004 |
| Bos taurus |
Calf thymus DNA |
Activity |
nan |
None |
10.1021/jm00228a006 |
| Bos taurus |
Calf thymus DNA |
Bapp |
0.108 |
None |
10.1021/jm00141a007 |
| Bos taurus |
Calf thymus DNA |
Delta Tm |
7.1 |
degrees C |
10.1021/jm00194a006 |
| Bos taurus |
Calf thymus DNA |
Delta Tm |
7.1 |
degrees C |
10.1021/jm00218a013 |
| Bos taurus |
Calf thymus DNA |
Delta Tm |
8.7 |
degrees C |
10.1021/jm00195a008 |
| Bos taurus |
Calf thymus DNA |
IC50 |
35000.0 |
nM |
10.1016/j.bmcl.2006.05.065 |
| Bos taurus |
Calf thymus DNA |
Ka |
1.56 |
10'6/M |
10.1021/jm00205a004 |
| Bos taurus |
Calf thymus DNA |
K app |
230000000.0 |
M-1 |
10.1021/jm00141a007 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
MIC |
0.06 |
ug.mL-1 |
10.1021/acs.jnatprod.1c00294 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Chlorocebus sabaeus |
Vero |
IC50 |
1.0 |
nM |
10.1021/np050240y |
| Chlorocebus sabaeus |
Vero |
IC50 |
10.0 |
nM |
10.1016/j.bmcl.2014.03.051 |
| Chlorocebus sabaeus |
Vero |
IC50 |
11.0 |
nM |
10.1016/j.ejmech.2017.09.004 |
| Chlorocebus sabaeus |
Vero |
IC50 |
71.0 |
nM |
10.1016/j.ejmech.2012.05.032 |
| Chlorocebus sabaeus |
Vero |
IC50 |
71.0 |
nM |
10.1016/j.ejmech.2017.09.004 |
| Chlorocebus sabaeus |
Vero |
IC50 |
71.0 |
nM |
10.1021/np050240y |
| Chlorocebus sabaeus |
Vero |
IC50 |
72.0 |
nM |
10.1016/j.bmcl.2014.03.051 |
| Chlorocebus sabaeus |
Vero |
IC50 |
11000.0 |
nM |
10.1016/j.ejmech.2010.10.023 |
| Chlorocebus sabaeus |
Vero |
IC50 |
11000.0 |
nM |
10.1021/jm050772b |
| Chlorocebus sabaeus |
Vero |
Ratio IC50 |
0.4 |
None |
10.1016/j.bmcl.2014.03.051 |
| Chlorocebus sabaeus |
Vero |
Ratio IC50 |
1.6 |
None |
10.1016/j.bmcl.2014.03.051 |
| Chlorocebus sabaeus |
Vero |
Ratio IC50 |
3.0 |
None |
10.1016/j.ejmech.2012.05.032 |
| Cyberlindnera jadinii |
Cyberlindnera jadinii |
Activity |
nan |
None |
10.1021/np50055a002 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
-2.56 |
% |
10.1016/j.bmc.2012.09.040 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
0.06 |
ug.mL-1 |
10.1021/acs.jnatprod.1c00294 |
| Enterococcus faecium |
Enterococcus faecium |
MIC |
0.13 |
ug.mL-1 |
10.1021/acs.jnatprod.1c00294 |
| Equus caballus |
Cholinesterase |
Inhibition |
3.31 |
% |
10.1016/j.bmc.2012.09.040 |
| Equus caballus |
Ferritin light chain |
Potency |
31622.8 |
nM |
None |
| Escherichia coli |
Escherichia coli |
IZ |
20.0 |
mm |
10.1021/np060063g |
| Escherichia coli |
Escherichia coli |
MIC |
9.57 |
ug.mL-1 |
10.1021/acs.jnatprod.6b00742 |
| Escherichia coli K-12 |
DNA-directed RNA polymerase beta chain |
K app |
2.3e-05 |
M-1 |
10.1021/jm00357a025 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
7062.7 |
nM |
None |
| Homo sapiens |
5637 |
IC50 |
3.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
5637 |
IC50 |
3.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
5637 |
IC50 |
3.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
A2780 |
Activity |
0.0017 |
uM |
10.1021/np0504107 |
| Homo sapiens |
A2780 |
IC50 |
0.001 |
ug.mL-1 |
10.1021/np020578h |
| Homo sapiens |
A2780 |
IC50 |
0.001 |
ug.mL-1 |
10.1021/np040058h |
| Homo sapiens |
A2780 |
IC50 |
0.001 |
ug.mL-1 |
10.1021/np049639x |
| Homo sapiens |
A2780 |
IC50 |
0.001 |
ug.mL-1 |
10.1021/np050376w |
| Homo sapiens |
A2780 |
IC50 |
0.002 |
ug.mL-1 |
10.1021/np0201220 |
| Homo sapiens |
A2780 |
IC50 |
0.8 |
nM |
10.1021/np049629w |
| Homo sapiens |
A2780 |
IC50 |
0.8 |
nM |
10.1021/np050202e |
| Homo sapiens |
A-375 |
Inhibition |
0.7 |
% |
10.1016/j.bmcl.2009.06.063 |
| Homo sapiens |
A549 |
Activity |
0.0 |
% |
10.1021/acs.jnatprod.9b01015 |
| Homo sapiens |
A549 |
Activity |
40.0 |
% |
10.1016/j.ejmech.2010.10.023 |
| Homo sapiens |
A549 |
Activity |
40.0 |
% |
10.1016/j.ejmech.2012.02.038 |
| Homo sapiens |
A549 |
EC50 |
0.201 |
nM |
10.1021/acs.jnatprod.6b00742 |
| Homo sapiens |
A549 |
IC50 |
7.2 |
nM |
10.1016/j.ejmech.2012.05.032 |
| Homo sapiens |
A549 |
IC50 |
7.2 |
nM |
10.1016/j.ejmech.2017.09.004 |
| Homo sapiens |
A549 |
IC50 |
8.0 |
nM |
10.1016/j.ejmech.2017.09.004 |
| Homo sapiens |
A549 |
IC50 |
3800.0 |
nM |
10.1021/acs.jnatprod.1c00294 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
ACHN |
IC50 |
5.0 |
nM |
10.1016/j.ejmech.2019.111960 |
| Homo sapiens |
ACHN |
IC50 |
5.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
ACHN |
IC50 |
5.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
ACHN |
IC50 |
5.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
Potency |
20.0 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
25.1 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
39.8 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
10.1124/mol.63.1.65 |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
1412.5 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
BEAS-2B |
IC50 |
700.0 |
nM |
10.1021/acs.jnatprod.1c00294 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile acid receptor FXR |
Potency |
11.2 |
nM |
None |
| Homo sapiens |
Bile acid receptor FXR |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
AC50 |
34000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bloom syndrome protein |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Bloom syndrome protein |
Potency |
18211.8 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
C8166 |
IC50 |
0.08 |
nM |
10.1021/jm020918w |
| Homo sapiens |
C8166 |
IC50 |
0.8 |
nM |
10.1021/jm020913z |
| Homo sapiens |
C8166 |
IC50 |
0.8 |
nM |
10.1021/jm050745l |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Ca-Ski |
ED50 |
1.9 |
10'-3 ug/ml |
10.1021/np0101651 |
| Homo sapiens |
Ca-Ski |
ED50 |
1.9 |
10'-3 ug/ml |
10.1021/np980281c |
| Homo sapiens |
Ca-Ski |
ED50 |
1.9 |
10'-3 ug/ml |
10.1021/np9900167 |
| Homo sapiens |
Ca-Ski |
ED50 |
1.9 |
10'-3 ug/ml |
10.1021/np990367l |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Caspase-7 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CCRF-CEM |
Activity |
nan |
None |
10.1016/j.bmc.2008.02.063 |
| Homo sapiens |
CCRF-CEM |
IC50 |
1.0 |
nM |
10.1016/j.ejmech.2019.111960 |
| Homo sapiens |
CCRF-CEM |
IC50 |
1.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
CCRF-CEM |
IC50 |
1.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
CCRF-CEM |
IC50 |
1.6 |
nM |
10.1016/j.bmc.2008.02.063 |
| Homo sapiens |
CCRF-CEM |
IC50 |
3.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
CCRF-CEM |
IC50 |
1600.0 |
nM |
10.1021/jm030253d |
| Homo sapiens |
CCRF-CEM |
ID50 |
10.0 |
ng/ml |
10.1021/jm00193a009 |
| Homo sapiens |
CCRF-CEM |
ID50 |
10.0 |
ng/ml |
10.1021/jm00207a021 |
| Homo sapiens |
CCRF-CEM |
ID50 |
13.0 |
ng ml-1 |
10.1021/jm00392a018 |
| Homo sapiens |
CCRF-CEM |
ID50 |
13.0 |
ng ml-1 |
10.1021/jm00399a018 |
| Homo sapiens |
CCRF-CEM |
ID50 |
40.0 |
ng ml-1 |
10.1021/jm00365a015 |
| Homo sapiens |
CCRF-CEM |
ID50 |
60.0 |
ng ml-1 |
10.1021/jm00141a007 |
| Homo sapiens |
CCRF-SB |
IC50 |
1.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
CCRF-SB |
IC50 |
2.0 |
nM |
10.1016/j.ejmech.2019.111960 |
| Homo sapiens |
CCRF-SB |
IC50 |
2.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
CCRF-SB |
IC50 |
2.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
2.0 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
CRL-7065 cell line |
IC50 |
7.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
11639.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
20730.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ratio IC50 |
2.0 |
None |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ratio IC50 |
2.0 |
None |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ratio IC50 |
2.0 |
None |
10.1021/tx300075j |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Discoidin domain-containing receptor 2 |
IC50 |
9000.0 |
nM |
10.1021/jm5012319 |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
DU-145 |
IC50 |
8.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
4.0 |
nM |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
35.5 |
nM |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
G-361 |
IC50 |
1.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
G-361 |
IC50 |
1.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
G-361 |
IC50 |
1.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
G-361 |
IC50 |
6.0 |
nM |
10.1016/j.ejmech.2019.111960 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
112.2 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
125.9 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
141.3 |
nM |
None |
| Homo sapiens |
Growth factor receptor-bound protein 2 |
IC50 |
5000.0 |
nM |
10.1016/s0960-894x(98)00345-x |
| Homo sapiens |
HCT-116 |
ED50 |
nan |
None |
10.1021/np0101651 |
| Homo sapiens |
HCT-15 |
GI |
49.0 |
% |
10.1007/s00044-011-9899-3 |
| Homo sapiens |
HeLa |
Activity |
nan |
None |
10.1016/j.bmc.2014.06.032 |
| Homo sapiens |
HeLa |
Activity |
nan |
None |
10.1016/j.ejmech.2012.05.032 |
| Homo sapiens |
HeLa |
Activity |
nan |
None |
10.1016/j.ejmech.2017.09.004 |
| Homo sapiens |
HeLa |
IC50 |
0.01 |
ug.mL-1 |
10.1021/np970573y |
| Homo sapiens |
HeLa |
IC50 |
0.4 |
nM |
10.1021/np700717s |
| Homo sapiens |
HeLa |
IC50 |
1.0 |
nM |
10.1021/np050240y |
| Homo sapiens |
HeLa |
IC50 |
1.1 |
nM |
10.1016/j.bmcl.2014.03.051 |
| Homo sapiens |
HeLa |
IC50 |
1.1 |
nM |
10.1016/j.ejmech.2012.05.032 |
| Homo sapiens |
HeLa |
IC50 |
1.1 |
nM |
10.1016/j.ejmech.2017.09.004 |
| Homo sapiens |
HeLa |
IC50 |
1.6 |
nM |
10.1016/j.bmcl.2014.03.051 |
| Homo sapiens |
HeLa |
IC50 |
3.2 |
nM |
10.1016/j.ejmech.2017.09.004 |
| Homo sapiens |
HeLa |
IC50 |
8.0 |
nM |
10.1016/j.ejmech.2019.111960 |
| Homo sapiens |
HeLa |
IC50 |
8.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
HeLa |
IC50 |
11.0 |
nM |
10.1021/np050240y |
| Homo sapiens |
HeLa |
IC50 |
40.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
HeLa |
IC50 |
40.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
HeLa |
IC50 |
120.0 |
nM |
10.1021/acs.jnatprod.1c00294 |
| Homo sapiens |
HeLa |
IC50 |
262.4 |
nM |
10.1038/nchembio.304 |
| Homo sapiens |
HeLa |
IC50 |
519.7 |
nM |
10.1038/nchembio.304 |
| Homo sapiens |
HeLa |
Inhibition |
nan |
% |
10.1038/nchembio.304 |
| Homo sapiens |
HeLa |
Ratio IC50 |
6.3 |
None |
10.1016/j.bmcl.2014.03.051 |
| Homo sapiens |
HeLa |
Ratio IC50 |
65.5 |
None |
10.1016/j.bmcl.2014.03.051 |
| Homo sapiens |
HEp-2 |
IC50 |
4.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
HEp-2 |
IC50 |
4.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
HEp-2 |
IC50 |
4.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
HEp-2 |
IC50 |
6.0 |
nM |
10.1021/np050240y |
| Homo sapiens |
HEp-2 |
IC50 |
191.0 |
nM |
10.1021/np050240y |
| Homo sapiens |
HepG2 |
ED50 |
nan |
None |
10.1021/np0101651 |
| Homo sapiens |
HepG2 |
GI |
42.0 |
% |
10.1007/s00044-011-9899-3 |
| Homo sapiens |
HepG2 |
GI50 |
1000.0 |
nM |
10.1021/np990416u |
| Homo sapiens |
HepG2 |
IC50 |
10.0 |
nM |
10.1021/acs.jnatprod.1c00294 |
| Homo sapiens |
HepG2 |
IC50 |
10.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
HepG2 |
IC50 |
10.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
HepG2 |
LC50 |
50000.0 |
nM |
10.1021/np990416u |
| Homo sapiens |
HepG2 |
TGI |
4000.0 |
nM |
10.1021/np990416u |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
891.3 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
HL-60 |
IC50 |
20.0 |
nM |
10.1021/acs.jnatprod.1c00294 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
Apoptotic index |
35.5 |
None |
10.1021/jm000058o |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
8.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fabs |
5.0 |
% |
10.1124/dmd.110.034629 |
| Homo sapiens |
Homo sapiens |
IC50 |
4.5 |
nM |
10.1021/jm000058o |
| Homo sapiens |
Homo sapiens |
IC80 |
0.0072 |
uM |
10.1021/jm000058o |
| Homo sapiens |
Homo sapiens |
ID50 |
60.0 |
ng ml-1 |
10.1021/jm00352a023 |
| Homo sapiens |
Homo sapiens |
Inhibition |
49.2 |
% |
10.1021/jm000058o |
| Homo sapiens |
Homo sapiens |
Inhibition |
90.5 |
% |
10.1021/jm000058o |
| Homo sapiens |
HT-29 |
Activity |
nan |
None |
10.1021/np50063a010 |
| Homo sapiens |
HT-29 |
ED50 |
nan |
None |
10.1021/np0101651 |
| Homo sapiens |
HT-29 |
IC50 |
2.9 |
nM |
10.1021/np700717s |
| Homo sapiens |
HT-29 |
IC50 |
6.0 |
nM |
10.1016/j.ejmech.2019.111960 |
| Homo sapiens |
HT-29 |
IC50 |
6.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
HT-29 |
IC50 |
6.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
HT-29 |
IC50 |
6.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
HT-29 |
IC50 |
100.0 |
nM |
10.1021/jm00399a014 |
| Homo sapiens |
HT-29 |
IC50 |
223.0 |
nM |
10.1021/np50063a010 |
| Homo sapiens |
HT-29 |
IC50 |
900.0 |
nM |
10.1021/jm00399a014 |
| Homo sapiens |
HT-3 |
ED50 |
5.6 |
10'-4 ug/ml |
10.1021/np980281c |
| Homo sapiens |
HT-3 |
ED50 |
5.6 |
10'-4 ug/ml |
10.1021/np9900167 |
| Homo sapiens |
HT-3 |
ED50 |
5.6 |
10'-4 ug/ml |
10.1021/np990367l |
| Homo sapiens |
Huh-7 |
CC50 |
4180.0 |
nM |
10.1073/pnas.0802982105 |
| Homo sapiens |
Huh-7 |
CC50 |
10000.0 |
nM |
10.1073/pnas.0802982105 |
| Homo sapiens |
Huntingtin |
Potency |
31.6 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
251.2 |
nM |
None |
| Homo sapiens |
IMR-32 |
Activity |
nan |
None |
10.1021/jm020913z |
| Homo sapiens |
Interleukin-8 |
Potency |
133.3 |
nM |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Jurkat |
FC |
4.3 |
None |
10.1021/np900314p |
| Homo sapiens |
Jurkat |
FC |
5.7 |
None |
10.1021/np900314p |
| Homo sapiens |
Jurkat |
IC50 |
4.5 |
nM |
10.1021/jm9806695 |
| Homo sapiens |
Jurkat |
IC80 |
0.0072 |
uM |
10.1021/jm9806695 |
| Homo sapiens |
Jurkat |
Inhibition |
51.8 |
% |
10.1021/jm9806695 |
| Homo sapiens |
Jurkat |
Inhibition |
63.2 |
% |
10.1021/jm9806695 |
| Homo sapiens |
K562 |
Activity |
2.0 |
% |
10.1016/j.bmcl.2011.02.026 |
| Homo sapiens |
K562 |
Activity |
58.0 |
% |
10.1016/j.bmcl.2011.02.026 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
KB |
IC50 |
0.01 |
ug.mL-1 |
10.1021/np010071r |
| Homo sapiens |
KB |
IC50 |
0.01 |
ug.mL-1 |
10.1021/np0202273 |
| Homo sapiens |
KB |
IC50 |
1.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
KB |
IC50 |
4.0 |
nM |
10.1021/jm030918b |
| Homo sapiens |
KB |
IC50 |
50.0 |
nM |
10.1021/jm030918b |
| Homo sapiens |
KB |
IC50 |
200.0 |
nM |
10.1021/jm030918b |
| Homo sapiens |
L02 |
IC50 |
500.0 |
nM |
10.1021/acs.jnatprod.1c00294 |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Liver microsomes |
Activity |
nan |
None |
10.1021/tx300075j |
| Homo sapiens |
Liver microsomes |
Stability |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
2.5 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
3.2 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
4.0 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
5.0 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
6.3 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
7.9 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
10.0 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
12.6 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
15.8 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
20.0 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
39.8 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
794.3 |
nM |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
ED50 |
nan |
None |
10.1021/np0101651 |
| Homo sapiens |
MCF7 |
GI50 |
500.0 |
nM |
10.1021/np990416u |
| Homo sapiens |
MCF7 |
IC50 |
6.0 |
nM |
10.1016/j.ejmech.2019.111960 |
| Homo sapiens |
MCF7 |
IC50 |
6.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
MCF7 |
IC50 |
6.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
MCF7 |
IC50 |
24.0 |
nM |
10.1016/j.ejmech.2012.05.032 |
| Homo sapiens |
MCF7 |
IC50 |
24.0 |
nM |
10.1016/j.ejmech.2017.09.004 |
| Homo sapiens |
MCF7 |
IC50 |
48.0 |
nM |
10.1016/j.ejmech.2017.09.004 |
| Homo sapiens |
MCF7 |
IC50 |
103.0 |
nM |
10.1021/np100014j |
| Homo sapiens |
MCF7 |
IC50 |
200.0 |
nM |
10.1021/acs.jnatprod.1c00294 |
| Homo sapiens |
MCF7 |
LC50 |
50000.0 |
nM |
10.1021/np990416u |
| Homo sapiens |
MCF7 |
TGI |
2200.0 |
nM |
10.1021/np990416u |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
MOLT-3 |
AC50 |
nan |
None |
10.1021/jm050772b |
| Homo sapiens |
MOLT-3 |
CC50 |
nan |
None |
10.1021/jm050772b |
| Homo sapiens |
MOLT-3 |
IC50 |
1000.0 |
nM |
10.1016/j.ejmech.2010.10.023 |
| Homo sapiens |
MOLT-3 |
IC50 |
1000.0 |
nM |
10.1021/jm050772b |
| Homo sapiens |
MOLT-4 |
IC50 |
1.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
MOLT-4 |
IC50 |
1.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
MOLT-4 |
IC50 |
1.0 |
nM |
10.1021/jm050745l |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
MRC5 |
IC50 |
0.02 |
ug.mL-1 |
10.1016/j.bmcl.2004.06.083 |
| Homo sapiens |
MT4 |
IC50 |
0.9 |
nM |
10.1021/jm020918w |
| Homo sapiens |
MT4 |
IC50 |
0.9 |
nM |
10.1021/jm050745l |
| Homo sapiens |
MT4 |
IC50 |
1.0 |
nM |
10.1016/j.ejmech.2019.111960 |
| Homo sapiens |
MT4 |
IC50 |
1.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
Multidrug resistance-associated protein 6 |
Activity |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
NCI-H157 |
Activity |
3.0 |
% |
10.1016/j.bmc.2012.07.013 |
| Homo sapiens |
NCI-H157 |
Activity |
9.0 |
% |
10.1016/j.bmc.2012.07.013 |
| Homo sapiens |
NCI-H157 |
Activity |
23.0 |
% |
10.1016/j.bmc.2012.07.013 |
| Homo sapiens |
NCI-H157 |
Activity |
nan |
None |
10.1016/j.bmc.2012.07.013 |
| Homo sapiens |
NCI-H460 |
IC50 |
8.0 |
nM |
10.1021/np100014j |
| Homo sapiens |
NCI-H522 |
GI |
59.0 |
% |
10.1007/s00044-011-9899-3 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
42.2 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
61.1 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
167.9 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
863.5 |
nM |
None |
| Homo sapiens |
Nuclear receptor ROR-gamma |
Potency |
26.6 |
nM |
None |
| Homo sapiens |
NUGC |
Activity |
0.0 |
% |
10.1021/np020007p |
| Homo sapiens |
NUGC |
IC50 |
6.61 |
ug.mL-1 |
10.1021/np020441r |
| Homo sapiens |
PA-1 |
GI |
93.0 |
% |
10.1007/s00044-011-9899-3 |
| Homo sapiens |
Panel leukemia (Carcinoma cell lines) |
CC50 |
3.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
PC-3 |
Activity |
0.0 |
% |
10.1021/acs.jnatprod.9b01015 |
| Homo sapiens |
PC-3 |
EC50 |
0.276 |
nM |
10.1021/acs.jnatprod.6b00742 |
| Homo sapiens |
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase |
Delta Tm |
2.95 |
degrees C |
10.1016/j.bmc.2016.08.019 |
| Homo sapiens |
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase |
Kd |
88500.0 |
nM |
10.1016/j.bmc.2016.08.019 |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
4.5 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
10.0 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
22.4 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
15.8 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
17.8 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
100.0 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
125.9 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1016/j.bbrc.2004.01.156 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
Km |
10000.0 |
nM |
10.1073/pnas.89.18.8472 |
| Homo sapiens |
P-glycoprotein 1 |
% maximum response |
1.39 |
% |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
0.21 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
16.0 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_ATPase activity |
1.2 |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_Papp |
80.0 |
None |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Raji |
IC50 |
2.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
Raji |
IC50 |
2.0 |
nM |
10.1021/jm020918w |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
11.2 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
14.1 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
31.6 |
nM |
None |
| Homo sapiens |
RKO |
IC50 |
30.0 |
nM |
10.1021/acs.jnatprod.1c00294 |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SF-268 |
IC50 |
16.0 |
nM |
10.1021/np100014j |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SiHa |
ED50 |
8.1 |
10'-4 ug/ml |
10.1021/np0101651 |
| Homo sapiens |
SiHa |
ED50 |
8.1 |
10'-4 ug/ml |
10.1021/np980281c |
| Homo sapiens |
SiHa |
ED50 |
8.1 |
10'-4 ug/ml |
10.1021/np9900167 |
| Homo sapiens |
SiHa |
ED50 |
8.1 |
10'-4 ug/ml |
10.1021/np990367l |
| Homo sapiens |
SK-MEL-28 |
IC50 |
2.0 |
nM |
10.1016/j.ejmech.2019.111960 |
| Homo sapiens |
SK-MEL-28 |
IC50 |
2.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
SK-MES-1 |
IC50 |
4.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
Solute carrier family 22 member 5 |
Activity |
69.0 |
% |
None |
| Homo sapiens |
Solute carrier family 22 member 5 |
Activity |
nan |
None |
None |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
57.98 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
85.16 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
T-24 |
ED50 |
1.5 |
10'-3 ug/ml |
10.1021/np980281c |
| Homo sapiens |
T-24 |
ED50 |
1.5 |
10'-3 ug/ml |
10.1021/np9900167 |
| Homo sapiens |
T-24 |
ED50 |
1.5 |
10'-3 ug/ml |
10.1021/np990367l |
| Homo sapiens |
T47D |
GI |
21.0 |
% |
10.1007/s00044-011-9899-3 |
| Homo sapiens |
Telomerase reverse transcriptase |
Inhibition |
50.0 |
% |
10.1016/s0960-894x(01)00553-4 |
| Homo sapiens |
THP-1 |
IC50 |
nan |
None |
10.1021/jm050772b |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
0.7 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
50.1 |
nM |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
6.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
6.7 |
nM |
None |
| Homo sapiens |
U2OS |
IC50 |
3.2 |
nM |
10.1021/np700717s |
| Homo sapiens |
U-937 |
IC50 |
1000.0 |
nM |
10.1021/jm050772b |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
25.1 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
WIL2-NS |
IC50 |
3.0 |
nM |
10.1021/jm020913z |
| Homo sapiens |
WIL2-NS |
IC50 |
3.0 |
nM |
10.1021/jm050745l |
| Human betaherpesvirus 5 |
Human betaherpesvirus 5 |
Inhibition |
nan |
% |
10.1128/aac.01730-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
IC50 |
270000.0 |
nM |
10.1016/j.bmcl.2012.05.041 |
| Micrococcus luteus |
Micrococcus luteus |
MIC |
0.003 |
ug.mL-1 |
10.1021/acs.jnatprod.6b00742 |
| Micrococcus luteus |
Micrococcus luteus |
MIC |
0.06 |
ug.mL-1 |
10.1021/acs.jnatprod.1c00294 |
| Mucor hiemalis |
Mucor hiemalis |
MIC |
3.12 |
ug.mL-1 |
10.1021/np0602057 |
| Mus musculus |
B16 |
ID50 |
3.0 |
nM |
10.1021/jm00403a010 |
| Mus musculus |
B16 |
ID50 |
3.3 |
ng ml-1 |
10.1021/jm00392a018 |
| Mus musculus |
B16 |
ID50 |
3.3 |
ng ml-1 |
10.1021/jm00399a018 |
| Mus musculus |
B16 |
ILS |
38.0 |
% |
10.1021/jm00228a006 |
| Mus musculus |
B16 |
ILS |
48.0 |
% |
10.1021/jm00228a006 |
| Mus musculus |
B16 |
ILS |
48.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
B16 |
ILS |
61.0 |
% |
10.1021/jm00228a006 |
| Mus musculus |
B16 |
MST |
38.5 |
day |
10.1021/jm00228a006 |
| Mus musculus |
B16 |
MST |
41.5 |
day |
10.1021/jm00228a006 |
| Mus musculus |
B16 |
MST |
43.0 |
None |
10.1021/jm00399a014 |
| Mus musculus |
B16 |
MST |
45.0 |
day |
10.1021/jm00228a006 |
| Mus musculus |
Dihydrofolate reductase |
Log 1/C |
7.75 |
None |
10.1021/jm00369a019 |
| Mus musculus |
Dihydrofolate reductase |
Log 1/C |
7.76 |
None |
10.1021/jm00369a019 |
| Mus musculus |
Growth factor receptor-bound protein 2 |
IC50 |
5000.0 |
nM |
10.1016/s0960-894x(00)00258-4 |
| Mus musculus |
Growth factor receptor-bound protein 2 |
Inhibition |
40.1 |
% |
10.1016/s0960-894x(00)00258-4 |
| Mus musculus |
Growth factor receptor-bound protein 2 |
Inhibition |
50.5 |
% |
10.1016/s0960-894x(00)00258-4 |
| Mus musculus |
L1210 |
DOSE |
0.025 |
mg.kg-1 |
10.1021/jm00403a010 |
| Mus musculus |
L1210 |
ED50 |
0.009 |
uM |
10.1021/jm00218a013 |
| Mus musculus |
L1210 |
ED50 |
0.015 |
uM |
10.1021/jm00194a006 |
| Mus musculus |
L1210 |
ED50 |
0.4 |
uM |
10.1021/jm00218a013 |
| Mus musculus |
L1210 |
ED50 |
0.6 |
uM |
10.1021/jm00194a006 |
| Mus musculus |
L1210 |
IC50 |
19.0 |
nM |
10.1021/jm00403a010 |
| Mus musculus |
L1210 |
IC50 |
380.0 |
nM |
10.1021/jm00403a010 |
| Mus musculus |
L1210 |
ID50 |
0.001 |
uM |
10.1021/jm00185a012 |
| Mus musculus |
L1210 |
ID50 |
0.001 |
uM |
10.1021/jm00356a012 |
| Mus musculus |
L1210 |
ID50 |
60.1 |
nM |
10.1021/jm00403a010 |
| Mus musculus |
L1210 |
ILS |
31.0 |
% |
10.1021/jm00228a006 |
| Mus musculus |
L1210 |
ILS |
42.0 |
% |
10.1021/jm00228a006 |
| Mus musculus |
L1210 |
ILS |
45.0 |
% |
10.1021/jm00228a006 |
| Mus musculus |
L1210 |
Inhibition |
51.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
L1210 |
Inhibition |
57.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
L1210 |
Inhibition |
78.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
L1210 |
Inhibition |
97.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
L1210 |
Inhibition |
98.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
L1210 |
Inhibition |
99.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
L1210 |
K |
1000.0 |
uM-1 |
10.1021/jm00356a012 |
| Mus musculus |
L1210 |
Log CR |
0.12 |
None |
10.1021/jm00169a014 |
| Mus musculus |
L1210 |
MST |
12.6 |
day |
10.1021/jm00228a006 |
| Mus musculus |
L1210 |
MST |
13.6 |
day |
10.1021/jm00228a006 |
| Mus musculus |
L1210 |
MST |
14.0 |
day |
10.1021/jm00228a006 |
| Mus musculus |
MC-38 |
Inhibition |
30.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
Inhibition |
67.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
Inhibition |
83.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
Inhibition |
89.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
T/C |
100.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
T/C |
103.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
T/C |
107.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
T/C |
134.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
T/C |
170.0 |
% |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
Toxic deaths |
0.0 |
None |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
Toxic deaths |
1.0 |
None |
10.1021/jm00399a014 |
| Mus musculus |
MC-38 |
Toxic deaths |
4.0 |
None |
10.1021/jm00399a014 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm00195a008 |
| Mus musculus |
Mus musculus |
Cures |
1.0 |
None |
10.1021/jm00365a015 |
| Mus musculus |
Mus musculus |
Dose |
0.25 |
mg ml-1 |
10.1021/jm00403a010 |
| Mus musculus |
Mus musculus |
Dose |
0.3 |
mg ml-1 |
10.1021/jm00403a010 |
| Mus musculus |
Mus musculus |
Dose |
0.9 |
mg ml-1 |
10.1021/jm00403a010 |
| Mus musculus |
Mus musculus |
ILS |
36.0 |
% |
10.1021/jm00403a010 |
| Mus musculus |
Mus musculus |
ILS |
52.0 |
% |
10.1021/jm00403a010 |
| Mus musculus |
Mus musculus |
ILS |
55.0 |
% |
10.1021/jm00403a010 |
| Mus musculus |
Mus musculus |
MST |
29.0 |
day |
10.1021/jm00403a010 |
| Mus musculus |
Mus musculus |
MST |
33.5 |
day |
10.1021/jm00403a010 |
| Mus musculus |
Mus musculus |
MST |
45.0 |
day |
10.1021/jm00403a010 |
| Mus musculus |
Mus musculus |
T/C |
165.0 |
None |
10.1021/jm00108a009 |
| Mus musculus |
Mus musculus |
Weight |
95.0 |
% |
10.1021/jm00047a002 |
| Mus musculus |
Mus musculus |
Weight |
98.6 |
% |
10.1021/jm00047a002 |
| Mus musculus |
Mus musculus |
Weight |
101.6 |
% |
10.1021/jm00047a002 |
| Mus musculus |
Mus musculus |
Weight |
103.0 |
% |
10.1021/jm00047a002 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
17.8 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
22.4 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
31.6 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
89.1 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
19952.6 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
89125.1 |
nM |
None |
| Mus musculus |
P388 |
Activity |
0.001 |
ug ml-1 |
10.1021/np700738k |
| Mus musculus |
P388 |
Activity |
25.0 |
% |
10.1021/jm00205a004 |
| Mus musculus |
P388 |
Activity |
nan |
None |
10.1021/jm00193a009 |
| Mus musculus |
P388 |
Activity |
nan |
None |
10.1021/np50063a010 |
| Mus musculus |
P388 |
Cure |
0.0 |
None |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
Cure |
1.0 |
None |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
ED50 |
0.046 |
uM |
10.1021/jm00141a007 |
| Mus musculus |
P388 |
ED50 |
0.996 |
uM |
10.1021/jm00141a007 |
| Mus musculus |
P388 |
IC50 |
0.2 |
nM |
10.1021/np50063a010 |
| Mus musculus |
P388 |
IC50 |
50.0 |
nM |
10.1021/jm00399a014 |
| Mus musculus |
P388 |
IC50 |
1100.0 |
nM |
10.1021/jm00399a014 |
| Mus musculus |
P388 |
ILS |
0.25 |
% |
10.1021/jm00399a014 |
| Mus musculus |
P388 |
ILS |
18.0 |
% |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
ILS |
45.0 |
% |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
ILS |
55.0 |
% |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
ILS |
100.0 |
% |
10.1021/jm00218a013 |
| Mus musculus |
P388 |
ILS |
110.0 |
% |
10.1021/jm00228a006 |
| Mus musculus |
P388 |
ILS |
122.0 |
% |
10.1021/jm00207a021 |
| Mus musculus |
P388 |
ILS |
129.0 |
% |
10.1021/jm00141a007 |
| Mus musculus |
P388 |
ILS |
136.0 |
% |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
ILS |
136.0 |
% |
10.1021/jm00365a015 |
| Mus musculus |
P388 |
ILS |
171.0 |
% |
10.1021/jm00228a006 |
| Mus musculus |
P388 |
ILS |
262.0 |
% |
10.1021/jm00228a006 |
| Mus musculus |
P388 |
IZ |
5.0 |
mm |
10.1021/np50063a010 |
| Mus musculus |
P388 |
MED |
0.05 |
None |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
MED |
0.0625 |
None |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
MST |
8.0 |
day |
10.1021/jm00193a009 |
| Mus musculus |
P388 |
MST |
9.0 |
day |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
MST |
13.0 |
day |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
MST |
16.0 |
day |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
MST |
17.0 |
day |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
MST |
22.0 |
day |
10.1021/jm00228a006 |
| Mus musculus |
P388 |
MST |
24.0 |
day |
10.1021/jm00141a007 |
| Mus musculus |
P388 |
MST |
26.0 |
day |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
MST |
26.0 |
day |
10.1021/jm00365a015 |
| Mus musculus |
P388 |
MST |
28.0 |
day |
10.1021/jm00193a009 |
| Mus musculus |
P388 |
MST |
28.5 |
day |
10.1021/jm00228a006 |
| Mus musculus |
P388 |
MST |
30.0 |
day |
10.1021/jm00193a009 |
| Mus musculus |
P388 |
MST |
38.0 |
day |
10.1021/jm00228a006 |
| Mus musculus |
P388 |
MTD |
0.15 |
None |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
MTD |
0.25 |
None |
10.1021/jm00352a023 |
| Mus musculus |
P388 |
Optimal dose |
125.0 |
ug kg-1 |
10.1021/jm00141a007 |
| Mus musculus |
P388 |
Survival |
5.0 |
day |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
Survival |
8.0 |
day |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
Survival |
10.0 |
day |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
Survival |
15.0 |
day |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
Survival |
18.0 |
day |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
Survival |
19.0 |
day |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
Survival |
31.0 |
% |
10.1021/jm00193a009 |
| Mus musculus |
P388 |
Survival |
141.0 |
% |
10.1021/jm00193a009 |
| Mus musculus |
P388 |
Survival |
149.0 |
% |
10.1021/jm00193a009 |
| Mus musculus |
P388 |
T/C |
48.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
T/C |
76.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
T/C |
95.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
T/C |
143.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
T/C |
171.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
P388 |
T/C |
181.0 |
% |
10.1021/jm00195a008 |
| Mus musculus |
P388/ADR |
Dose |
0.075 |
None |
10.1021/jm00403a010 |
| Mus musculus |
P388/ADR |
ID50 |
2500.0 |
nM |
10.1021/jm00403a010 |
| Mus musculus |
P388/ADR |
ILS |
33.0 |
% |
10.1021/jm00403a010 |
| Mus musculus |
P388/ADR |
MST |
12.0 |
day |
10.1021/jm00403a010 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
1.0 |
ug.mL-1 |
10.1021/acs.jnatprod.6b00235 |
| Mycobacterium tuberculosis |
Pantothenate synthetase |
Activity |
1.6 |
10'12L/mol/s |
10.1016/j.bmcl.2011.05.021 |
| Mycobacterium tuberculosis |
Pantothenate synthetase |
Activity |
8.18 |
% |
10.1016/j.bmcl.2011.05.021 |
| Mycobacterium tuberculosis |
Pantothenate synthetase |
Activity |
47.81 |
% |
10.1016/j.bmcl.2011.05.021 |
| Mycobacterium tuberculosis |
Pantothenate synthetase |
IC50 |
250720.0 |
nM |
10.1016/j.bmcl.2011.05.021 |
| Mycobacterium tuberculosis |
Pantothenate synthetase |
IC50 |
250720.0 |
nM |
10.1016/j.ejmech.2013.08.036 |
| Mycobacterium tuberculosis variant bovis |
Mycobacterium tuberculosis variant bovis |
MIC |
0.2 |
ug.mL-1 |
10.1021/acs.jnatprod.6b00235 |
| Mycolicibacterium aurum |
Mycolicibacterium aurum |
MIC |
0.6 |
ug.mL-1 |
10.1021/acs.jnatprod.6b00742 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Penicillium griseofulvum |
Penicillium griseofulvum |
MIC |
3.12 |
ug.mL-1 |
10.1021/np0602057 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
214.5 |
nM |
10.1073/pnas.0802982105 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
323.0 |
nM |
10.1073/pnas.0802982105 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
395.0 |
nM |
10.1073/pnas.0802982105 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
807.0 |
nM |
10.1073/pnas.0802982105 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2.4 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
4.8 |
nM |
None |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
B104 |
GI50 |
0.7 |
nM |
10.1016/s0960-894x(00)00258-4 |
| Rattus norvegicus |
C6 |
Activity |
nan |
None |
10.1021/np960144k |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
7.1 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
9074.3 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
10.0 |
% |
10.1021/jm00399a014 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
22.0 |
% |
10.1021/jm00399a014 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
100.0 |
% |
10.1021/jm00399a014 |
| Rattus norvegicus |
Rattus norvegicus |
Adrenochrome formation |
2.29 |
nM min-1 (mg of protein)-1 |
10.1021/jm00399a014 |
| Rattus norvegicus |
Rattus norvegicus |
Adrenochrome formation |
nan |
None |
10.1021/jm00399a014 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41500.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
44000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
262.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
279.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
297.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
363.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
370.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
374.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
41.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
41.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
46.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
49.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
51.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
52.83 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
79.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
85.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
89.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
100.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
130.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
3.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
140.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
148.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
150.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
151.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
156.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
193.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.17 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
623.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
635.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
695.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
770.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
813.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
853.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
327.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
333.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
488.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
494.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
562.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
1455.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
25670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
28830000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
29000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.6 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.5 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
24.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
33.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
221.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1486.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1543.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1553.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1556.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1630.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1650.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
32.63 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
33.7 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.02 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.57 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
128700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
134300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
136700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
137700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
138200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
139700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
134.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
269.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
357.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
429.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
502.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
798.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
11.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
7777.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
11832.83 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12123.5 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12705.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
13429.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
13952.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
85.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
87.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
88.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
90.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
93.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.67 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.13 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.5 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.68 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.98 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
25.37 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
377700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
393700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
394800.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
395000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
398000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
405700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.7 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.17 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.42 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.57 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.63 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.23 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
103.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
151.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
166.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
243.5 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
267.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
279.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
2.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NADPH oxidation |
10.01 |
nM min-1 (mg of protein)-1 |
10.1021/jm00399a014 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
5.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
7.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
9.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
9.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
10.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
12.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
748.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1069.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1138.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1282.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1369.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1446.17 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
105.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
110.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
112.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
117.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
119.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
123.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1053000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1114500.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1121670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1163670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1178170.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1209000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.31 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.85 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.37 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.38 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58500.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
62000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5180000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5390000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5610000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5630000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5680000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5810000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.17 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
140.17 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
140.87 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.68 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
142.45 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.1 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.37 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
12.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
13.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
14.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
16.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
17.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
9070.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
13580.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
13680.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14400.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14770.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14870.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
IZ |
1.0 |
mm |
10.1016/j.ejmech.2010.07.050 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
IZ |
3.0 |
mm |
10.1016/j.ejmech.2010.07.050 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
MIC |
4.79 |
ug.mL-1 |
10.1021/acs.jnatprod.6b00742 |
| Sarcina |
Sarcina |
MIC |
0.045 |
ug.mL-1 |
10.1021/jm00228a006 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
4.878 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.08 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
20.86 |
% |
10.21203/rs.3.rs-23951/v1 |
| Stachybotrys chartarum |
Stachybotrys chartarum |
MIC |
3.12 |
ug.mL-1 |
10.1021/np0602057 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
30.0 |
mm |
10.1021/np060063g |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.006 |
ug.mL-1 |
10.1021/acs.jnatprod.6b00742 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.05 |
ug.mL-1 |
10.1021/jm00228a006 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.06 |
ug.mL-1 |
10.1021/acs.jnatprod.1c00294 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.25 |
ug.mL-1 |
10.1021/jm00108a009 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.625 |
ug.mL-1 |
10.1016/j.bmc.2010.02.005 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.0 |
ug.mL-1 |
10.1021/acs.jnatprod.1c00294 |
| Trichoderma harzianum |
Trichoderma harzianum |
MIC |
6.25 |
ug.mL-1 |
10.1021/np0602057 |
| Trypanosoma cruzi |
Cruzipain |
Potency |
3981.1 |
nM |
None |
| Trypanosoma cruzi |
Cruzipain |
Potency |
12589.3 |
nM |
None |
| Yarrowia lipolytica |
Yarrowia lipolytica |
MIC |
6.25 |
ug.mL-1 |
10.1021/np0602057 |
| None |
ADMET |
Delta Tm |
8.0 |
degrees C |
10.1021/jm00399a018 |
| None |
ADMET |
ED50 |
nan |
None |
10.1021/np9900167 |
| None |
ADMET |
IC50 |
5.0 |
nM |
10.1021/jm020913z |
| None |
ADMET |
IC50 |
50.0 |
nM |
10.1021/jm020913z |
| None |
ADMET |
IC50 |
200.0 |
nM |
10.1021/jm020913z |
| None |
ADMET |
Papp |
0.4 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
0.8 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
2.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
4.5 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
8.2 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
9.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
10.1 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
-82.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
-25.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
4.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
4.4 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
5.4 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
6.4 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
15.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
28.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
55.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
75.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
115.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
178.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
182.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Therapeutic index |
3.0 |
None |
10.1021/jm00352a023 |
| None |
ADMET |
Therapeutic index |
4.0 |
None |
10.1021/jm00352a023 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
2.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
29.6 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
23.7 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Molecular identity unknown |
Potency |
105.9 |
nM |
None |
| None |
Molecular identity unknown |
Potency |
70794.6 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1016/j.bmc.2014.06.032 |
| None |
NON-PROTEIN TARGET |
CC50 |
2.0 |
nM |
10.1021/jm020913z |
| None |
NON-PROTEIN TARGET |
CC50 |
5.0 |
nM |
10.1021/jm020913z |
| None |
NON-PROTEIN TARGET |
ED50 |
0.01 |
ug ml-1 |
10.1021/np50086a002 |
| None |
NON-PROTEIN TARGET |
ED50 |
1.4 |
10'-3 ug/ml |
10.1021/np980281c |
| None |
NON-PROTEIN TARGET |
ED50 |
1.4 |
10'-3 ug/ml |
10.1021/np9900167 |
| None |
NON-PROTEIN TARGET |
ED50 |
1.4 |
10'-3 ug/ml |
10.1021/np990367l |
| None |
NON-PROTEIN TARGET |
ED50 |
nan |
None |
10.1021/np0101651 |
| None |
NON-PROTEIN TARGET |
ED50 |
nan |
None |
10.1021/np980281c |
| None |
NON-PROTEIN TARGET |
ED50 |
nan |
None |
10.1021/np990367l |
| None |
NON-PROTEIN TARGET |
GI50 |
1.2 |
nM |
10.1021/np060063g |
| None |
NON-PROTEIN TARGET |
GI50 |
1.6 |
nM |
10.1021/np060063g |
| None |
NON-PROTEIN TARGET |
GI50 |
1.9 |
nM |
10.1021/np060063g |
| None |
NON-PROTEIN TARGET |
GI50 |
300.0 |
nM |
10.1021/np990416u |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
8.8 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
8.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
12.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
0.01 |
ug.mL-1 |
10.1021/np010071r |
| None |
NON-PROTEIN TARGET |
IC50 |
0.01 |
ug.mL-1 |
10.1021/np0202273 |
| None |
NON-PROTEIN TARGET |
IC50 |
0.01 |
ug.mL-1 |
10.1021/np970573y |
| None |
NON-PROTEIN TARGET |
IC50 |
3.0 |
nM |
10.1021/jm020918w |
| None |
NON-PROTEIN TARGET |
IC50 |
4.53 |
ug.mL-1 |
10.1021/np020441r |
| None |
NON-PROTEIN TARGET |
IC50 |
6.2 |
nM |
10.1016/j.bmcl.2014.03.051 |
| None |
NON-PROTEIN TARGET |
IC50 |
170.0 |
nM |
10.1016/j.bmcl.2014.03.051 |
| None |
NON-PROTEIN TARGET |
LC50 |
50000.0 |
nM |
10.1021/np990416u |
| None |
NON-PROTEIN TARGET |
LC50 |
nan |
None |
10.1016/j.bmcl.2010.01.033 |
| None |
NON-PROTEIN TARGET |
TGI |
6.4 |
nM |
10.1021/np060063g |
| None |
NON-PROTEIN TARGET |
TGI |
8.8 |
nM |
10.1021/np060063g |
| None |
NON-PROTEIN TARGET |
TGI |
52.0 |
nM |
10.1021/np060063g |
| None |
NON-PROTEIN TARGET |
TGI |
800.0 |
nM |
10.1021/np990416u |
| None |
No relevant target |
LogD |
3.21 |
None |
10.1021/jm00169a014 |
| None |
No relevant target |
LogP |
3.21 |
None |
10.1021/jm00369a019 |
| None |
Nucleic Acid |
Activity |
30.0 |
% |
10.1021/np50078a006 |
| None |
Nucleic Acid |
Binding Decrease |
63.0 |
% |
10.1016/j.bmcl.2010.01.033 |
| None |
Nucleic Acid |
Delta Tm |
8.0 |
degrees C |
10.1021/jm00357a025 |
| None |
Nucleic Acid |
Delta Tm |
10.0 |
degrees C |
10.1016/j.bmcl.2010.01.033 |
| None |
Nucleic Acid |
Delta Tm |
45.0 |
degrees C |
10.1016/j.bmcl.2010.01.033 |
| None |
Nucleic Acid |
EC50 |
4300.0 |
nM |
10.1016/j.bmcl.2010.01.033 |
| None |
Nucleic Acid |
Inhibition |
nan |
% |
10.1016/j.bmcl.2011.12.103 |
| None |
Nucleic Acid |
Log Kd |
nan |
None |
10.1021/jm00370a007 |
| None |
Nucleic Acid |
rel T |
100.0 |
None |
10.1021/jm00357a025 |
| None |
Nucleic Acid |
Time constant |
19.0 |
s |
10.1021/jm030253d |
| None |
Nucleic Acid |
Time constant |
68.0 |
s |
10.1021/jm030253d |
| None |
Nucleic Acid |
Time constant |
719.0 |
s |
10.1021/jm030253d |
| None |
Unchecked |
Ac50 |
0.5012 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.631 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.8913 |
uM |
None |
| None |
Unchecked |
Ac50 |
2.512 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.548 |
uM |
None |
| None |
Unchecked |
AC50 |
501.2 |
nM |
None |
| None |
Unchecked |
AC50 |
631.0 |
nM |
None |
| None |
Unchecked |
AC50 |
891.3 |
nM |
None |
| None |
Unchecked |
AC50 |
2511.9 |
nM |
None |
| None |
Unchecked |
AC50 |
3550.0 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2010.07.050 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/jm00218a013 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/jm00228a006 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/np0504107 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/np960144k |
| None |
Unchecked |
Change in Tm |
8.0 |
None |
10.1021/jm00392a018 |
| None |
Unchecked |
Delta Tm |
7.1 |
degrees C |
10.1021/jm00365a015 |
| None |
Unchecked |
Hepatotoxicity (acute) |
7.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
16.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
6.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
1.0 |
nM |
10.1021/acs.jnatprod.0c01103 |
| None |
Unchecked |
IC50 |
1.0 |
nM |
None |
| None |
Unchecked |
IC50 |
1.5 |
nM |
None |
| None |
Unchecked |
IC50 |
37.0 |
nM |
None |
| None |
Unchecked |
IC50 |
40.31 |
nM |
None |
| None |
Unchecked |
IC50 |
14640000.0 |
nM |
10.1016/j.bmcl.2021.127787 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
IFI |
18.03 |
% |
10.1073/pnas.0802982105 |
| None |
Unchecked |
IFI |
20.31 |
% |
10.1073/pnas.0802982105 |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Log CR |
2.58 |
None |
10.1021/jm00169a014 |
| None |
Unchecked |
MIC |
9.57 |
ug.mL-1 |
10.1021/acs.jnatprod.6b00742 |
| None |
Unchecked |
Potency |
25.1 |
nM |
None |
| None |
Unchecked |
Potency |
50.1 |
nM |
None |
| None |
Unchecked |
Potency |
70.8 |
nM |
None |
| None |
Unchecked |
Potency |
1258.9 |
nM |
None |
| None |
Unchecked |
Potency |
1995.3 |
nM |
None |
| None |
Unchecked |
Potency |
3548.1 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Ratio |
3.0 |
None |
10.1016/j.bmcl.2003.12.015 |
| None |
Unchecked |
Ratio |
26.0 |
None |
10.1021/jm00403a010 |
| None |
Unchecked |
Tm |
7.1 |
degrees C |
10.1021/jm00352a023 |